Small-molecule GSDMD agonism in tumors stimulates antitumor immunity without toxicity
Cell · 2024-10 · 187 (22) · 6165-6181.e22
DOI: 10.1016/j.cell.2024.08.007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell, 2024-10. Verfasst von Pietro Fontana und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA; Program in Cellular and Molecular Medic…. Hauptthemen laut MEDLINE: Pyroptosis, Phosphate-Binding Proteins, Intracellular Signaling Peptides and Proteins. Die Arbeit wurde bisher 132-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIAID NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA; Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA 02115, USA.
- Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA 02115, USA; Department of Pediatrics, Harvard Medical School, Boston, MA 02115, USA; Key Laboratory of Cell Proliferation and Differenti…
- Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA 02115, USA; Department of Pediatrics, Harvard Medical School, Boston, MA 02115, USA.
- Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA; Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA 02115, USA; School of Life…
- Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Immunology, Harvard Medical School, Boston, MA 02215, USA.
- Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA; Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA 02115, USA; Zhejiang Provi…
Förderung
- NHLBI NIH HHS
- NIAID NIH HHS
- NCI NIH HHS
- Boston Children's Hospital
- National Institutes of Health
- Deutsche Forschungsgemeinschaft
- American Cancer Society
- Cancer Research Institute
Zitieren
APA
Fontana, P., Du, G., Zhang, Y., Zhang, H., Vora, S. M., Hu, J. J., Shi, M., Tufan, A. B., Healy, L. B., Xia, S., Lee, D. J., Li, Z., Baldominos, P., Ru, H., Luo, H. R., Agudo, J., Lieberman, J., & Wu, H. (2024). Small-molecule GSDMD agonism in tumors stimulates antitumor immunity without toxicity. Cell, 187(22), 6165-6181.e22. https://doi.org/10.1016/j.cell.2024.08.007
Vancouver
Fontana P, Du G, Zhang Y, Zhang H, Vora SM, Hu JJ, et al. Small-molecule GSDMD agonism in tumors stimulates antitumor immunity without toxicity. Cell. 2024;187(22):6165-6181.e22. doi:10.1016/j.cell.2024.08.007
BibTeX
@article{Fontana2024,
author = {Fontana, Pietro and Du, Gang and Zhang, Ying and Zhang, Haiwei and Vora, Setu M and Hu, Jun Jacob and Shi, Ming and Tufan, Ahmet B and Healy, Liam B and Xia, Shiyu and Lee, Dian-Jang and Li, Zhouyihan and Baldominos, Pilar and Ru, Heng and Luo, Hongbo R and Agudo, Judith and Lieberman, Judy and Wu, Hao},
title = {Small-molecule GSDMD agonism in tumors stimulates antitumor immunity without toxicity},
journal = {Cell},
year = {2024},
volume = {187},
number = {22},
pages = {6165--6181.e22},
doi = {10.1016/j.cell.2024.08.007}
}
EUVIMED